The rescue effect of TAK1 is yet to be confirmed in transgenic mice, but results suggest that TAK1-activation of NF-kB drives insulin resistance and lipid accumulation and is at least partially controlled by DUSP26. Here, DUSP26 is linked to Insulin resistance.